SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-15-008770
Filing Date
2015-11-16
Accepted
2015-11-16 17:29:55
Documents
1
Period of Report
2015-11-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3111215kelly_relmadatherap.html 3  
1 OWNERSHIP DOCUMENT f3111215kelly_relmadatherap.xml 3 2994
  Complete submission text file 0001213900-15-008770.txt   4445
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST 56TH STREET, APT 19E NEW YORK, NY 10022
Business Address
Kelly Paul Edward (Reporting) CIK: 0001658544 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55347 | Film No.: 151236428